Skip to main content
OpenTrials
Completed

NCT Number: NCT00365014

Progression of Hematopoietic Diseases in Shanghai, China

The purpose of this study is to identify and characterize blood diseases presenting at Shanghai hospitals and to compare them with respect to clinical presentation, phenotype, molecular characteristics, benzene or other exposures and genetic susceptibility.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hematologic Diseases Anemia Anemia, Aplastic Bone Marrow Diseases Bone Marrow Failure Disorders Cytopenia Hemic and Lymphatic Diseases Leukemia Leukemia, Myeloid Leukemia, Myeloid, Acute Myelodysplastic Syndromes Myelodysplastic-Myeloproliferative Diseases Neoplasms Neoplasms by Histologic Type

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Joint Sino-US Clinical and Molecular Laboratory (JCML)

Shanghai, 200032, China

About this study

The purpose of this study is to identify and characterize blood diseases presenting at Shanghai hospitals and to compare them with respect to clinical presentation, phenotype, molecular characteristics, benzene or other exposures and genetic susceptibility. The format for these studies is a set of clinical series superimposed on a case-control design that enables integration of detailed clinical and molecular characterizations of disease pathogenesis together with an evaluation of potential confounding and interacting factors within a structured statistical analysis of benzene exposure.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Men and women 18 years or older Diagnosis of hematologic abnormality

Exclusion criteria

Children Non hematologic diseases

Treatment and study plan

Primary outcomes

  1. blood diseases presenting at Shanghai hospitals

    Time frame: hospital stay

    characterization of people with blood diseases presenting at Shanghai hospitals

Sponsors and collaborators

Lead sponsor

University of Colorado, Denver

Other

Collaborators

  • British Petroleum P.L.C.
  • Chevron Corporation
  • ConocoPhillips
  • Exxon Mobil
  • ExxonMobil Biomedical Sciences, Inc.
  • Fudan University
  • Marathon Ashland
  • Shell Chemicals
  • University of Cincinnati

Registry information

Official study title

Analysis of Disease Progression for Aplastic Anemia, Myelodysplastic Syndrome, Acute Myeloid Leukemia and Benzene Poisoning in Shanghai, China.

Important dates

Study start
2003
Primary completion
2009
Study completion
2009
First posted
Aug 16, 2006
Registry last updated
Jul 23, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.